CD200分子(CD200)活性蛋白
Active Cluster Of Differentiation 200 (CD200)
MOX1; MOX2; MRC; OX-2; My033; Antigen Identified By Monoclonal Antibody MRC OX-2
- 編號(hào)APA880Hu01
 - 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
 - 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
 - 性狀凍干粉
 - 純度> 90%
 - 等電點(diǎn)8.2
 - 應(yīng)用Cell?culture;?Activity?Assays.
 - 下載英文說明書 中文說明書
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價(jià)格¥ 960¥ 2400¥ 4800¥ 14400¥ 36000
 - 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
活性實(shí)驗(yàn)

Cluster Of Differentiation 200 (CD200), also known as OX-2 or MOX1/MOX2, is a membrane glycoprotein belonging to the immunoglobulin superfamily. This protein is widely expressed in various cell types, including neurons, endothelial cells, certain immune cells (such as B cells, dendritic cells, T cell subsets), and various tumor cells. CD200 is a multifaceted protein with important roles in immune regulation, neuronal function, and disease pathogenesis. Besides, Cluster Of Differentiation 8a (CD8a) has been identified as an interactor of CD200, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human CD200 and recombinant human CD8a. Briefly, CD200 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to CD8a-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-CD200 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450/630 nm immediately. The binding activity of recombinant recombinant human CD200 and recombinant human CD8a was shown in Figure 1, the EC50?for this effect is 0.44 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| EPA880Hu61 | CD200分子(CD200)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| APA880Hu01 | CD200分子(CD200)活性蛋白 | Cell?culture;?Activity?Assays. | 
| RPA880Hu01 | CD200分子(CD200)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA880Hu01 | CD200分子(CD200)多克隆抗體 | WB; IHC | 
| FAA880Hu01 | 抗CD200分子(CD200)多克隆抗體 | Flow cytometry. | 
| FAA880Hu41 | 抗CD200分子(CD200)多克隆抗體(藻紅素標(biāo)記) | Flow cytometry. | 
| FAA880Hu51 | 抗CD200分子(CD200)多克隆抗體(別藻藍(lán)蛋白標(biāo)記) | Flow cytometry. | 
| FAA880Hu81 | 抗CD200分子(CD200)多克隆抗體(異硫氰酸熒光素標(biāo)記) | Flow cytometry. | 
| FAA880Hu31 | 抗CD200分子(CD200)多克隆抗體(別藻藍(lán)蛋白/花青染料cy7標(biāo)記) | FCM | 
| MAA880Hu23 | CD200分子(CD200)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA880Hu24 | CD200分子(CD200)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAA880Hu22 | CD200分子(CD200)單克隆抗體 | WB; IHC; ICC; IP. | 
| RAA880Hu21 | CD200分子(CD200)重組抗體 | WB; IFC; IHC; IP; FCM | 
| FAA880Hu02 | 抗CD200分子(CD200)單克隆抗體 | FCM | 
| FAA880Hu04 | 抗CD200分子(CD200)單克隆抗體 | FCM | 
| FAA880Hu06 | 抗CD200分子(CD200)單克隆抗體 | FCM | 
| FAA880Hu08 | 抗CD200分子(CD200)單克隆抗體 | FCM | 
| SEA880Hu | CD200分子(CD200)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMA880Hu | CD200分子(CD200)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Journal of Maternal-Fetal and Neonatal Medicine | Amniotic fluid CD200 levels in pregnancies complicated by preterm prelabor rupture of the membranes[PubMed: 23489112] | 
| Journal of Maternal-Fetal and Neonatal Medicine | Amniotic fluid CD200 levels in pregnancies complicated by preterm prelabor rupture of the membranes.[Pubmed: 23489112] | 
| Medicine | Pre-transplant CD200 and CD200R1 concentrations are associated with post-transplant events in kidney transplant recipients[Pubmed: 31517819] | 
| Molecular Biology Reports | Umbilical cord-derived mesenchymal stem cell conditioned medium reverses neuronal oxidative injury by inhibition of TRPM2 activation and the JNK signaling?…[Pubmed:35585377] | 



